Correlation of Xenon-enhanced Computed Tomography-defined Cerebral Blood Flow Reactivity and Collateral Flow Patterns
Overview
Neurology
Affiliations
Background And Purpose: A chronic compromise of cerebral hemodynamics has been shown to identify a group of patients at an increased risk for stroke. Because a "steal phenomenon" induced by a vasodilatory challenge has characterized the group at greatest risk, it was hypothesized that these individuals would also have a severe compromise of primary collaterals and an increased dependence on leptomeningeal collaterals.
Methods: Twenty-three patients with symptomatic cerebrovascular disease underwent angiography and xenon-enhanced computed tomographic cerebral blood flow studies before and after 1 g IV acetazolamide within 6 months of each other. Cerebral blood flow vasoreactivity was classified by whether cerebral blood flow increased (> 5%) or was unchanged (+/- 5%) (group 1) or fell by > 5% (group 2) in any vascular territory. Angiographic collateralization was classified into four types: normal (type 1), willisian (type 2), ophthalmic (type 3), and leptomeningeal (type 4).
Results: Twenty percent (2/10) of group 1 patients and 69% (9/13) of group 2 patients (P = .0009) had leptomeningeal collaterals.
Conclusions: A negative flow reactivity is significantly associated with a dependence on leptomeningeal collaterals and implies a state of maximal hemodynamic compromise.
Fahlstrom M, Svedung Wettervik T, Enblad P, Lewen A, Wikstrom J Front Neurol. 2023; 14:1137046.
PMID: 37325230 PMC: 10261981. DOI: 10.3389/fneur.2023.1137046.
Sebok M, van Niftrik C, Lohaus N, Esposito G, El Amki M, Winklhofer S J Cereb Blood Flow Metab. 2021; 41(11):3039-3051.
PMID: 34112002 PMC: 8545056. DOI: 10.1177/0271678X211024373.
Zarrinkoob L, Wahlin A, Ambarki K, Birgander R, Eklund A, Malm J Stroke. 2019; 50(5):1081-1088.
PMID: 30943887 PMC: 6485302. DOI: 10.1161/STROKEAHA.119.024757.
Kunieda T, Miyake K, Sakamoto H, Iwasaki Y, Iida S, Morise S Intern Med. 2017; 56(21):2857-2863.
PMID: 28943539 PMC: 5709627. DOI: 10.2169/internalmedicine.8397-16.
Derdeyn C J Cereb Blood Flow Metab. 2017; 38(9):1584-1597.
PMID: 28925313 PMC: 6125965. DOI: 10.1177/0271678X17732884.